Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
1996 2
2014 1
2021 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

5 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for J. venzon, III
Your search for J. Venzor, III retrieved no results
The immunological impact of adenovirus early genes on vaccine-induced responses in mice and nonhuman primates.
Sangare K, Tuero I, Rahman MA, Hoang T, Miller-Novak LK, Vargas-Inchaustegui DA, Venzon DJ, LaBranche C, Montefiori DC, Robert-Guroff M, Thomas MA. Sangare K, et al. J Virol. 2021 Mar 10;95(7):e02253-20. doi: 10.1128/JVI.02253-20. Epub 2021 Jan 13. J Virol. 2021. PMID: 33441339 Free PMC article.
The deltaE1/deltaE3 Ads are more popular because they can carry a larger transgene and because of the deleted E1 (E1A and E1B), are perceived safer for clinical use. Ad with a deletion in E1B55K (deltaE1B55K) has been in phase III clinical trials for use in cancer therapy …
The deltaE1/deltaE3 Ads are more popular because they can carry a larger transgene and because of the deleted E1 (E1A and E1B), are perceive …
Effects of therapeutic approach on the neonatal evolution of very low birth weight infants with patent ductus arteriosus.
Sadeck LS, Leone CR, Procianoy RS, Guinsburg R, Marba ST, Martinez FE, Rugolo LM, Moreira ME, Fiori RM, Ferrari LL, Menezes JA, Venzon PS, Abdallah VQ, Duarte JL, Nunes MV, Anchieta LM, Alves Filho N. Sadeck LS, et al. J Pediatr (Rio J). 2014 Nov-Dec;90(6):616-23. doi: 10.1016/j.jped.2014.04.010. Epub 2014 Jul 19. J Pediatr (Rio J). 2014. PMID: 25046256 Free article.

OBJECTIVE: To analyze the effects of treatment approach on the outcomes of newborns (birth weight [BW] < 1,000 g) with patent ductus arteriosus (PDA), from the Brazilian Neonatal Research Network (BNRN) on: death, bronchopulmonary dysplasia (BPD), severe intraventricular hemor

…

OBJECTIVE: To analyze the effects of treatment approach on the outcomes of newborns (birth weight [BW] < 1,000 g) with patent ductus arte

…
Pharmacologic variables associated with the development of neurologic toxicity in patients treated with suramin.
Bitton RJ, Figg WD, Venzon DJ, Dalakas MC, Bowden C, Headlee D, Reed E, Myers CE, Cooper MR. Bitton RJ, et al. J Clin Oncol. 1995 Sep;13(9):2223-9. doi: 10.1200/JCO.1995.13.9.2223. J Clin Oncol. 1995. PMID: 7666080 Clinical Trial.
The rate of drug infusion was continuously adjusted to maintain a preassigned plasma suramin concentration (175, 215, or 275 micrograms/mL) for a fixed duration (2 to 8 weeks). RESULTS: Eight patients developed grade III/IV neurologic motor impairment (predominantly motor …
The rate of drug infusion was continuously adjusted to maintain a preassigned plasma suramin concentration (175, 215, or 275 micrograms/mL) …
Lamivudine in children with human immunodeficiency virus infection: a phase I/II study. The National Cancer Institute Pediatric Branch-Human Immunodeficiency Virus Working Group.
Lewis LL, Venzon D, Church J, Farley M, Wheeler S, Keller A, Rubin M, Yuen G, Mueller B, Sloas M, Wood L, Balis F, Shearer GM, Brouwers P, Goldsmith J, Pizzo PA. Lewis LL, et al. J Infect Dis. 1996 Jul;174(1):16-25. doi: 10.1093/infdis/174.1.16. J Infect Dis. 1996. PMID: 8655986 Clinical Trial.